tiprankstipranks
Trending News
More News >
NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine
17d ago
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
Premium
The Fly
NRx Pharmaceuticals files ANDA for preservative-free IV ketamine
17d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
Premium
TipRanks Newswire
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
25d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup 
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup 
1M ago
NRx Pharmaceuticals Earnings Call Highlights Progress and Optimism
Premium
Company Announcements
NRx Pharmaceuticals Earnings Call Highlights Progress and Optimism
1M ago
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook
Premium
Ratings
NRX Pharmaceuticals: A Promising Investment with Innovative Growth and Strong Financial Outlook
1M ago
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
PremiumThe FlyPsychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
1M ago
NRx Pharmaceuticals Acquires Kadima Neuropsychiatry Institute
Premium
Company Announcements
NRx Pharmaceuticals Acquires Kadima Neuropsychiatry Institute
1M ago
Hope Therapeutics to acquire Kadima Neuropsychiatry Institute, no terms
Premium
The Fly
Hope Therapeutics to acquire Kadima Neuropsychiatry Institute, no terms
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100